AR and cancer: Testing of the association of E-cadherin mRNA expression with clinical risk factors in original 71 PTC samples showed that advanced cancer stage and extrathyroidal extension were associated with significantly lower E-cadherin expression (Figure S4A), providing further evidence that AR suppresses EMT during PTC tumorigenesis.